Company: APXIF
Filing Date: 2025-03-31
Form Type: F-4/A
Source: 0001213900-25-026339
Chunk: 29

Company: APx Acquisition Corp. I
Filing Date: 2025-03-31
Form: F-4/A
Chunk 29
---
 “CIBIC” means Centro de Diagnóstico Médico de Alta Complejidad S.A., a sociedad anónimaformed under the laws of Argentina. “CFC” means a controlled foreign corporation. “CLIA” means the Clinical Laboratory Improvement Amendments of 1988. “Closing” means the consummation of the Business Combination, including the Merger and other Transactions. “Closing Date” means the date upon which the Closing is to occur. iii “Combined Company” means the Company and its consolidated subsidiaries after giving effect to the Transactions. “Company” or “OmnigenicsAI” or “we” or “us” means OmnigenicsAI Corp, a Cayman Islands exempted company limited by shares. “Company Board” means the board of directors of the Company. “Company Disclosure Letter” means the disclosure letter delivered to SPAC by the Company on the date of the Business Combination Agreement. “Company Group” means the Company and its direct and indirect subsidiaries. “Company M&A” means the amended and restated memorandum and articles of association of the Company, to be effective upon the completion of the Business Combination. “Company Material Adverse Effect” means any event, state of facts, development, circumstance, occurrence or effect (collectively, “Events”) that (i) has had, or would reasonably be expected to have, individually or in the aggregate, a material adverse effect on the business, assets and liabilities, results of operations or financial condition of the Company and its Subsidiaries, taken as a whole or (ii) does or would reasonably be expected to, individually or in the aggregate, prevent or materially delay or materially adversely affect the ability of the Company to consummate the Transactions; provided that in no event would any of the following, alone or in combination, be deemed to constitute, or be taken into account in determining whether there has been or will be, a Company Material Adverse Effect: (a) any change in applicable Laws or IFRS or any interpretation thereof following the date of the Business Combination Agreement, (b) any change in interest rates or economic, political, business or financial market conditions generally, (c) the taking of any action or failure to take any action as required to be taken under the Business Combination Agreement, (d) any natural disaster (including hurricanes, storms, tornados, flooding, earthquakes, volcanic eruptions or similar occurrences), epidemic or pandemic (including any action taken or refrained from being taken in response to COVID -19